Trial intelligence / Profile preview

Sedation vs General Anesthesia in Therapeutic Bronchoscopy

NCT03983915Unknown

Sponsor
Changhai Hospital
Start
Jun 2019
Primary completion
Nov 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of dexmedetomidine and remifentanil in Respiratory diseases (2 arms), sponsored by Changhai Hospital. Primary endpoint: Recovery time up to 3 hours. Status: unknown.

02

Drugs

dexmedetomidineremifentanil
03

Conditions

Respiratory diseases

Beyond the preview

Go deeper on NCT03983915.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03983915.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call